VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...

VIC 2020 Annual Report Executive Summary

Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the The Annual Report Executive Summary or view it below.

VIC Fellows Spotlight: Kirt Gill, MD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Diabeloop SA and SFC Fluidics Announce Development Agreement

SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into...

CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software

CardioWise, Inc., is pleased to announce Clearance of its 510(k) application by the US Food and Drug Administration (FDA) for its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones...

A Letter from our CEO

When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.

FEATURED RESOURCES

News
Diabeloop SA and SFC Fluidics Announce Development Agreement
White Paper
Portfolio Diversification in Times of Market Volatility
Case Study
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
Updates
A Letter from our CEO
News
CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software
Case Study
Opportunity Assessment: How To Vet So Much Tech
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
News
VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries
Interview
VIC Fellows Spotlight: Travis Nemkov, PhD
From The Corner Office
Vixiar: Solving a Big Problem With a Small Device